Stay updated on Venetoclax in Relapsed AML Children Clinical Trial
Sign up to get notified when there's something new on the Venetoclax in Relapsed AML Children Clinical Trial page.

Latest updates to the Venetoclax in Relapsed AML Children Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov page footer now displays site revision v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check12 days agoChange DetectedAn NIH-wide notice says federal agencies are transitioning from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.5%

- Check19 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1. The study record information remains unchanged.SummaryDifference0.1%

- Check47 days agoChange DetectedAdds a new UI label 'Find contact information' and a new revision tag 'Revision: v3.7.0'; removes the previous label 'Find Contact Information' and the older revision 'Revision: v3.6.6' from the history.SummaryDifference0.1%

- Check68 days agoChange DetectedOn 2026-08-24, the history page added the Eligibility and Study Status sections and updated to Revision v3.6.6 (version 32). This update replaces the previous Revision v3.6.5 from 2026-05-19 and reflects a structural update to the study record history.SummaryDifference0.4%

Stay in the know with updates to Venetoclax in Relapsed AML Children Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax in Relapsed AML Children Clinical Trial page.